Status:
COMPLETED
PENG Block vs. ESP Block for Pediatric Hip Surgery
Lead Sponsor:
Poznan University of Medical Sciences
Conditions:
Hip Dysplasia
Hip Injuries
Eligibility:
All Genders
2-12 years
Phase:
PHASE4
Brief Summary
The study compares the effectiveness and safety of the pericapsular nerve blockade vs. ESPB in pediatric patients who underwent hip surgeries.
Detailed Description
The study compares the effectiveness and safety of the pericapsular nerve blockade vs. ESPB in pediatric patients who underwent hip surgeries. In addition, we aim to determine the optimal volume of lo...
Eligibility Criteria
Inclusion
- \- pediatric patients aged between 0-12 years who will undergo hip surgery
Exclusion
- a history of chronic pain use of gabapentin/pregabalin for \> 3 months opioid use \> 1 repeated opioid prescription in the last three months
- morbid obesity (BMI \> 99th percentile)
- Infection at block application area
- coagulopathy
Key Trial Info
Start Date :
October 17 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 23 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06087549
Start Date
October 17 2023
End Date
February 23 2024
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Spine Diseases and Pediatric Orthopedics, University of Medical Sciences, Poznań, Poland
Poznan, Wielkopolska, Poland, 61-545